title: cAMP signaling in skeletal muscle adaptation: hypertrophy, metabolism, and regeneration.
abstract: Among organ systems, skeletal muscle is perhaps the most structurally specialized. The remarkable subcellular architecture of this tissue allows it to empower movement with instructions from motor neurons. Despite this high degree of specialization, skeletal muscle also has intrinsic signaling mechanisms that allow adaptation to long-term changes in demand and regeneration after acute damage. The second messenger adenosine 3',5'-monophosphate (cAMP) not only elicits acute changes within myofibers during exercise but also contributes to myofiber size and metabolic phenotype in the long term. Strikingly, sustained activation of cAMP signaling leads to pronounced hypertrophic responses in skeletal myofibers through largely elusive molecular mechanisms. These pathways can promote hypertrophy and combat atrophy in animal models of disorders including muscular dystrophy, age-related atrophy, denervation injury, disuse atrophy, cancer cachexia, and sepsis. cAMP also participates in muscle development and regeneration mediated by muscle precursor cells; thus, downstream signaling pathways may potentially be harnessed to promote muscle regeneration in patients with acute damage or muscular dystrophy. In this review, we summarize studies implicating cAMP signaling in skeletal muscle adaptation. We also highlight ligands that induce cAMP signaling and downstream effectors that are promising pharmacological targets.
authors.affiliation: Department of Integrative Biology and Pharmacology, University of Texas Health Science Center at Houston, Houston, TX, USA. Rebecca.berdeaux@uth.tmc.edu
authors.forename: Rebecca
authors.initials: R
authors.lastname: Berdeaux
authors.forename: Randi
authors.initials: R
authors.lastname: Stewart
mesh_terms: D000222:Adaptation, Physiological; D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D000242:Cyclic AMP / Q000378:metabolism*; D015444:Exercise; D006801:Humans; D006984:Hypertrophy; D007103:Immobilization / Q000009:adverse effects*; D018482:Muscle, Skeletal / Q000201:enzymology / Q000293:injuries / Q000473:pathology / Q000502:physiology*; D009133:Muscular Atrophy / Q000209:etiology / Q000378:metabolism* / Q000473:pathology; D010805:Physical Conditioning, Animal; D012038:Regeneration; D015290:Second Messenger Systems
chemical_list: D000242:Cyclic AMP; D000262:Adenylyl Cyclases